{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:30:14Z","timestamp":1794346214395,"version":"4.9.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic retinopathy (DR), a complex condition driven by inflammation, oxidative stress, and metabolic imbalances, calls for innovative treatment strategies. Engineered probiotics delivering angiotensin-converting enzyme 2 (ACE2) offer a promising strategy by leveraging gut microbiome-retina association. Advances in synthetic biology and computational techniques enable personalized, data-driven therapies. This review discusses computational approaches at multiple scales and presents an integrated framework for promoting personalized, systems-level DR management.<\/jats:p>","DOI":"10.1038\/s41540-025-00607-w","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:41:41Z","timestamp":1763728901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systems biology and microbiome innovations for personalized diabetic retinopathy management"],"prefix":"10.1038","volume":"11","author":[{"given":"Javad","family":"Aminian-Dehkordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tamadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R. K.","family":"Mofrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"607_CR1","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study & GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 2000 to 2020. Eye 38, 2047\u20132057 (2024)."},{"key":"607_CR2","doi-asserted-by":"publisher","first-page":"930318","DOI":"10.3389\/fimmu.2022.930318","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu, K., Zou, J., Fan, H., Hu, H. & You, Z. Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study. Front. Immunol. 13, 930318 (2022).","journal-title":"Front. Immunol."},{"key":"607_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00253-024-13316-x","volume":"108","author":"X Qin","year":"2024","unstructured":"Qin, X. et al. Gut microbiota predict retinopathy in patients with diabetes: A longitudinal cohort study. Appl. Microbiol. Biotechnol. 108, 497 (2024).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"607_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.18240\/ijo.2024.05.13","volume":"17","author":"S-Q Jiang","year":"2024","unstructured":"Jiang, S.-Q. et al. Gut microbiota induced abnormal amino acids and their correlation with diabetic retinopathy. Int. J. Ophthalmol. 17, 883\u2013895 (2024).","journal-title":"Int. J. Ophthalmol."},{"key":"607_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.63.8.21","volume":"63","author":"PS Thakur","year":"2022","unstructured":"Thakur, P. S., Aggarwal, D., Takkar, B., Shivaji, S. & Das, T. Evidence suggesting the role of gut dysbiosis in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 63, 21 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"607_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.62.7.6","volume":"62","author":"L Zhou","year":"2021","unstructured":"Zhou, L. et al. Expression of the SARS-CoV-2 receptor ACE2 in Human Retina and Diabetes\u2014Implications for Retinopathy. Invest. Ophthalmol. Vis. Sci. 62, 6\u20136 (2021).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"607_CR7","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/eurheartj\/ehaa414","volume":"41","author":"GY Oudit","year":"2020","unstructured":"Oudit, G. Y. & Pfeffer, M. A. Plasma angiotensin-converting enzyme 2: Novel biomarker in heart failure with implications for COVID-19. Eur. Heart J. 41, 1818\u20131820 (2020).","journal-title":"Eur. Heart J."},{"key":"607_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11906-010-0122-6","volume":"12","author":"CN Bradford","year":"2010","unstructured":"Bradford, C. N., Ely, D. R. & Raizada, M. K. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy. Curr. Hypertens. Rep. 12, 212\u2013219 (2010).","journal-title":"Curr. Hypertens. Rep."},{"key":"607_CR9","first-page":"1852","volume":"26","author":"J-X Xie","year":"2022","unstructured":"Xie, J.-X., Hu, J., Cheng, J., Liu, C. & Wei, X. The function of the ACE2\/Ang(1-7)\/Mas receptor axis of the renin-angiotensin system in myocardial ischemia reperfusion injury. Eur. Rev. Med Pharm. Sci. 26, 1852\u20131859 (2022).","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"607_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13336-6","volume":"10","author":"P Praveschotinunt","year":"2019","unstructured":"Praveschotinunt, P. et al. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nat. Commun. 10, 5580 (2019).","journal-title":"Nat. Commun."},{"key":"607_CR11","doi-asserted-by":"publisher","first-page":"959441","DOI":"10.3389\/fbioe.2022.959441","volume":"10","author":"CM Robinson","year":"2022","unstructured":"Robinson, C. M., Short, N. E. & Riglar, D. T. Achieving spatially precise diagnosis and therapy in the mammalian gut using synthetic microbial gene circuits. Front. Bioeng. Biotechnol. 10, 959441 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"607_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt.3879","volume":"35","author":"DT Riglar","year":"2017","unstructured":"Riglar, D. T. et al. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat. Biotechnol. 35, 653\u2013658 (2017).","journal-title":"Nat. Biotechnol."},{"key":"607_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185034","volume":"15","author":"D Merenstein","year":"2023","unstructured":"Merenstein, D. et al. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes 15, 2185034 (2023).","journal-title":"Gut Microbes"},{"key":"607_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2337\/dc18-1809","volume":"42","author":"JA Lovshin","year":"2019","unstructured":"Lovshin, J. A. et al. Retinopathy and RAAS activation: Results from the Canadian Study of longevity in type 1 diabetes. Diab. Care 42, 273\u2013280 (2019).","journal-title":"Diab. Care"},{"key":"607_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/mt.2011.155","volume":"20","author":"A Verma","year":"2012","unstructured":"Verma, A. et al. ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy. Mol. Ther. 20, 28\u201336 (2012).","journal-title":"Mol. Ther."},{"key":"607_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13098-015-0086-4","volume":"7","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. High glucose induces and activates toll-like receptor 4 in endothelial cells of diabetic retinopathy. Diabetol. Metab. Syndr. 7, 89 (2015).","journal-title":"Diabetol. Metab. Syndr."},{"key":"607_CR17","doi-asserted-by":"publisher","first-page":"e4778","DOI":"10.1210\/clinem\/dgab469","volume":"106","author":"T Vezza","year":"2021","unstructured":"Vezza, T. & V\u00edctor, V. M. The HIF1\u03b1-PFKFB3 pathway: A key player in diabetic retinopathy. J. Clin. Endocrinol. Metab. 106, e4778\u2013e4780 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"607_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","volume":"3","author":"B Wang","year":"2015","unstructured":"Wang, B. et al. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Lancet Diab. Endocrinol. 3, 263\u2013274 (2015).","journal-title":"Lancet Diab. Endocrinol."},{"key":"607_CR19","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.exer.2019.107753","volume":"187","author":"JA Phipps","year":"2019","unstructured":"Phipps, J. A. et al. The renin-angiotensin system and the retinal neurovascular unit: A role in vascular regulation and disease. Exp. Eye Res. 187, 107753 (2019).","journal-title":"Exp. Eye Res."},{"key":"607_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.9.13.20","volume":"9","author":"A Verma","year":"2020","unstructured":"Verma, A. et al. Angiotensin-(1\u20137) expressed from lactobacillus bacteria protect diabetic retina in mice. Transl. Vis. Sci. Technol. 9, 20\u201320 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"607_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0489-7","volume":"13","author":"L Tao","year":"2016","unstructured":"Tao, L. et al. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-\u03baB pathways in human retinal pigment epithelium. J. Neuroinflamm. 13, 35 (2016).","journal-title":"J. Neuroinflamm."},{"key":"607_CR22","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/stem.2848","volume":"36","author":"Y Duan","year":"2018","unstructured":"Duan, Y. et al. Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction. Stem Cells 36, 1430\u20131440 (2018).","journal-title":"Stem Cells"},{"key":"607_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/978-981-13-7647-4_10","volume":"1141","author":"L Liu","year":"2019","unstructured":"Liu, L. & Liu, X. Roles of drug transporters in blood-retinal barrier. Adv. Exp. Med. Biol. 1141, 467\u2013504 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"607_CR24","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.1121\/10.0018190","volume":"153","author":"S Bleker","year":"2023","unstructured":"Bleker, S. et al. Modulation of the blood-retina-barrier permeability by focused ultrasound: Computational and experimental approaches. J. Acoust. Soc. Am. 153, A68\u2013A68 (2023).","journal-title":"J. Acoust. Soc. Am."},{"key":"607_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00125-024-06132-5","volume":"67","author":"A Eleftheriadou","year":"2024","unstructured":"Eleftheriadou, A. et al. Risk of diabetic retinopathy and diabetic macular oedema with sodium\u2013glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia 67, 1271\u20131282 (2024).","journal-title":"Diabetologia"},{"key":"607_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41433-019-0646-1","volume":"34","author":"I Toprak","year":"2020","unstructured":"Toprak, I., Fenkci, S. M., Fidan Yaylali, G., Martin, C. & Yaylali, V. Early retinal neurodegeneration in preclinical diabetic retinopathy: a multifactorial investigation. Eye (Lond.) 34, 1100\u20131107 (2020).","journal-title":"Eye (Lond.)"},{"key":"607_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13168","volume":"19","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell 19, e13168 (2020).","journal-title":"Aging Cell"},{"key":"607_CR28","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41440-023-01384-x","volume":"46","author":"K Gotoh","year":"2023","unstructured":"Gotoh, K. & Shibata, H. Association between the gut microbiome and the renin-angiotensin-aldosterone system: a possible link via the activation of the immune system. Hypertens. Res 46, 2315\u20132317 (2023).","journal-title":"Hypertens. Res"},{"key":"607_CR29","doi-asserted-by":"publisher","first-page":"G355","DOI":"10.1152\/ajpgi.00099.2021","volume":"321","author":"K Jaworska","year":"2021","unstructured":"Jaworska, K., Koper, M. & Ufnal, M. Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels. Am. J. Physiol. Gastrointest. Liver Physiol. 321, G355\u2013G366 (2021).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"607_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","volume":"47","author":"RN Vuille-dit-Bille","year":"2015","unstructured":"Vuille-dit-Bille, R. N. et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids 47, 693\u2013705 (2015).","journal-title":"Amino Acids"},{"key":"607_CR31","doi-asserted-by":"publisher","first-page":"1404678","DOI":"10.3389\/fcimb.2024.1404678","volume":"14","author":"L Song","year":"2024","unstructured":"Song, L., Ji, W. & Cao, X. Integrated analysis of gut microbiome and its metabolites in ACE2-knockout and ACE2-overexpressed mice. Front. Cell. Infect. Microbiol. 14, 1404678 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"607_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477\u2013481 (2012).","journal-title":"Nature"},{"key":"607_CR33","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1007\/s12035-024-04127-2","volume":"61","author":"L Jena","year":"2024","unstructured":"Jena, L. et al. Gene expression analysis in T2DM and its associated microvascular diabetic complications: Focus on risk factor and RAAS pathway. Mol. Neurobiol. 61, 8656\u20138667 (2024).","journal-title":"Mol. Neurobiol."},{"key":"607_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27472","volume":"10","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice. Heliyon 10, e27472 (2024).","journal-title":"Heliyon"},{"key":"607_CR35","doi-asserted-by":"publisher","first-page":"106920","DOI":"10.1016\/j.phrs.2023.106920","volume":"196","author":"X Mei","year":"2023","unstructured":"Mei, X. et al. Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats. Pharmacol. Res. 196, 106920 (2023).","journal-title":"Pharmacol. Res."},{"key":"607_CR36","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1039\/D1FO00515D","volume":"12","author":"Z Zeng","year":"2021","unstructured":"Zeng, Z., Guo, X., Zhang, J., Yuan, Q. & Chen, S. Lactobacillus paracasei modulates the gut microbiota and improves inflammation in type 2 diabetic rats. Food Funct. 12, 6809\u20136820 (2021).","journal-title":"Food Funct."},{"key":"607_CR37","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1021\/acs.jafc.1c07884","volume":"70","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Lactobacillus paracasei 24 Attenuates Lipid Accumulation in High-Fat Diet-Induced Obese Mice by Regulating the Gut Microbiota. J. Agric. Food Chem. 70, 4631\u20134643 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"607_CR38","first-page":"1771","volume":"12","author":"R Prasad","year":"2023","unstructured":"Prasad, R. et al. Sustained ACE2 expression by probiotic improves integrity of intestinal lymphatics and retinopathy in type 1 diabetic model. J. Clin. Med. Res. 12, 1771 (2023).","journal-title":"J. Clin. Med. Res."},{"key":"607_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943325","volume":"13","author":"L Li","year":"2022","unstructured":"Li, L. et al. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes. Front Immunol. 13, 943325 (2022).","journal-title":"Front Immunol."},{"key":"607_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt.3935","volume":"35","author":"C Quince","year":"2017","unstructured":"Quince, C., Walker, A. W., Simpson, J. T., Loman, N. J. & Segata, N. Shotgun metagenomics, from sampling to analysis. Nat. Biotechnol. 35, 833\u2013844 (2017).","journal-title":"Nat. Biotechnol."},{"key":"607_CR41","first-page":"491","volume":"471","author":"Nancy","year":"2021","unstructured":"Nancy, Boparai, J. K. & Sharma, P. K. Metatranscriptomics: A promising tool to depict dynamics of microbial community structure and function. Microb. Metatranscriptomics Belowground 471, 491 (2021).","journal-title":"Microb. Metatranscriptomics Belowground"},{"key":"607_CR42","first-page":"844","volume":"65","author":"R Prasad","year":"2024","unstructured":"Prasad, R. et al. Ile-Trp dipeptide prevents diabetic retinopathy via gut Indole\/AhR\/PXR signaling in type 2 diabetes. Invest. Ophthalmol. Vis. Sci. 65, 844\u2013844 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"607_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.822647","volume":"9","author":"C Guo","year":"2022","unstructured":"Guo, C. et al. High-coverage serum metabolomics reveals metabolic pathway dysregulation in diabetic retinopathy: A propensity score-matched study. Front Mol. Biosci. 9, 822647 (2022).","journal-title":"Front Mol. Biosci."},{"key":"607_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04259-4","volume":"21","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids. J. Transl. Med. 21, 451 (2023).","journal-title":"J. Transl. Med."},{"key":"607_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.667632","volume":"12","author":"P Ye","year":"2021","unstructured":"Ye, P. et al. Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy. Front Microbiol 12, 667632 (2021).","journal-title":"Front Microbiol"},{"key":"607_CR46","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3390\/cells10082119","volume":"10","author":"D Dao","year":"2021","unstructured":"Dao, D. et al. High-fat diet alters the retinal transcriptome in the absence of gut Microbiota. Cells 10, 2119 (2021).","journal-title":"Cells"},{"key":"607_CR47","doi-asserted-by":"publisher","unstructured":"Huang, Q. et al. Biomarker identification by proteomic analysis of vitreous humor and plasma in diabetic retinopathy. bioRxiv https:\/\/doi.org\/10.1101\/2024.05.18.594835 (2024).","DOI":"10.1101\/2024.05.18.594835"},{"key":"607_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88698-3","volume":"11","author":"K Becker","year":"2021","unstructured":"Becker, K. et al. In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy. Sci. Rep. 11, 10494 (2021).","journal-title":"Sci. Rep."},{"key":"607_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm-22-1546","volume":"10","author":"R Zhang","year":"2022","unstructured":"Zhang, R., Huang, C., Chen, Y., Li, T. & Pang, L. Single-cell transcriptomic analysis revealing changes in retinal cell subpopulation levels and the pathways involved in diabetic retinopathy. Ann. Transl. Med. 10, 562 (2022).","journal-title":"Ann. Transl. Med."},{"key":"607_CR50","doi-asserted-by":"publisher","first-page":"175628481985847","DOI":"10.1177\/1756284819858470","volume":"12","author":"M Mouzaki","year":"2019","unstructured":"Mouzaki, M. & Loomba, R. Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: Rationale and prospects for therapeutic intervention. Ther. Adv. Gastroenterol. 12, 1756284819858470 (2019).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"607_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00592-020-01610-9","volume":"58","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy. Acta Diabetol. 58, 221\u2013229 (2021).","journal-title":"Acta Diabetol."},{"key":"607_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/genes10020112","volume":"10","author":"D Ai","year":"2019","unstructured":"Ai, D. et al. Using decision tree aggregation with random forest model to identify gut microbes associated with colorectal cancer. Genes (Basel) 10, 112 (2019).","journal-title":"Genes (Basel)"},{"key":"607_CR53","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1161\/HYPERTENSIONAHA.120.15885","volume":"76","author":"S Aryal","year":"2020","unstructured":"Aryal, S., Alimadadi, A., Manandhar, I., Joe, B. & Cheng, X. Machine learning strategy for gut microbiome-based diagnostic screening of cardiovascular disease. Hypertension 76, 1555\u20131562 (2020).","journal-title":"Hypertension"},{"key":"607_CR54","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.micinf.2021.104892","volume":"24","author":"W Liu","year":"2022","unstructured":"Liu, W., Fang, X., Zhou, Y., Dou, L. & Dou, T. Machine learning-based investigation of the relationship between gut microbiome and obesity status. Microbes Infect. 24, 104892 (2022).","journal-title":"Microbes Infect."},{"key":"607_CR55","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/microorganisms8101612","volume":"8","author":"D Yang","year":"2020","unstructured":"Yang, D. & Xu, W. Clustering on human microbiome sequencing data: A distance-based unsupervised learning model. Microorganisms 8, 1612 (2020).","journal-title":"Microorganisms"},{"key":"607_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42788-0","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning, L. et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat. Commun. 14, 7135 (2023).","journal-title":"Nat. Commun."},{"key":"607_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.13.12.23","volume":"13","author":"Y Pang","year":"2024","unstructured":"Pang, Y. et al. Multi-omics integration with machine learning identified early diabetic retinopathy, diabetic macula edema and anti-VEGF treatment response. Trans. Vis. Sci. Tech. 13, 23\u201323 (2024).","journal-title":"Trans. Vis. Sci. Tech."},{"key":"607_CR58","doi-asserted-by":"publisher","first-page":"2224474","DOI":"10.1080\/19490976.2023.2224474","volume":"15","author":"O Shtossel","year":"2023","unstructured":"Shtossel, O., Isakov, H., Turjeman, S., Koren, O. & Louzoun, Y. Ordering taxa in image convolution networks improves microbiome-based machine learning accuracy. Gut Microbes 15, 2224474 (2023).","journal-title":"Gut Microbes"},{"key":"607_CR59","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. An explainable graph neural framework to identify cancer-associated intratumoral microbial communities. Adv. Sci. (Weinh.) 11, e2403393 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"607_CR60","doi-asserted-by":"publisher","first-page":"919380","DOI":"10.3389\/fmicb.2022.919380","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y. & Lei, X. Metapath aggregated graph neural network and tripartite heterogeneous networks for microbe-disease prediction. Front. Microbiol. 13, 919380 (2022).","journal-title":"Front. Microbiol."},{"key":"607_CR61","unstructured":"Irwin, C., Mignone, F., Montani, S. & Portinale, L. Graph neural networks for gut microbiome metaomic data: A preliminary work. arXiv [cs.LG] (2024)."},{"key":"607_CR62","doi-asserted-by":"crossref","unstructured":"Parsa, M., Aminian-Dehkordi, J. & Mofrad, M. R. K. SIMBA-GNN: Simulation-augmented microbiome abundance graph neural network. bioRxiv 2025\u20132005 (2025).","DOI":"10.1101\/2025.05.27.656377"},{"key":"607_CR63","doi-asserted-by":"publisher","first-page":"bbab477","DOI":"10.1093\/bib\/bbab477","volume":"23","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. iProbiotics: a machine learning platform for rapid identification of probiotic properties from whole-genome primary sequences. Brief Bioinform. 23, bbab477 (2022).","journal-title":"Brief Bioinform."},{"key":"607_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00346-24","volume":"9","author":"Y Yan","year":"2024","unstructured":"Yan, Y., Shi, Z. & Zhang, Y. Hierarchical multi-task deep learning-assisted construction of human gut microbiota reactive oxygen species-scavenging enzymes database. mSphere 9, e0034624 (2024).","journal-title":"mSphere"},{"key":"607_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011436","volume":"19","author":"JC Thompson","year":"2023","unstructured":"Thompson, J. C., Zavala, V. M. & Venturelli, O. S. Integrating a tailored recurrent neural network with Bayesian experimental design to optimize microbial community functions. PLoS Comput. Biol. 19, e1011436 (2023).","journal-title":"PLoS Comput. Biol."},{"key":"607_CR66","unstructured":"Dehkordi, J. A., Parsa, M. S., Naghipourfar, M. & Mofrad, M. KODA: An agentic framework for KEGG orthology-driven discovery of antimicrobial drug targets in gut microbiome. in ICML 2025 Generative AI and Biology (GenBio) Workshop (2025)."},{"key":"607_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1730-3","volume":"20","author":"C Gu","year":"2019","unstructured":"Gu, C., Kim, G. B., Kim, W. J., Kim, H. U. & Lee, S. Y. Current status and applications of genome-scale metabolic models. Genome Biol. 20, 121 (2019).","journal-title":"Genome Biol."},{"key":"607_CR68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211197119","volume":"119","author":"E Vayena","year":"2022","unstructured":"Vayena, E. et al. A workflow for annotating the knowledge gaps in metabolic reconstructions using known and hypothetical reactions. Proc. Natl. Acad. Sci. Usa. 119, e2211197119 (2022).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"607_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-024-00384-y","volume":"10","author":"YE Hsieh","year":"2024","unstructured":"Hsieh, Y. E., Tandon, K., Verbruggen, H. & Nikoloski, Z. Comparative analysis of metabolic models of microbial communities reconstructed from automated tools and consensus approaches. NPJ Syst. Biol. Appl. 10, 54 (2024).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"607_CR70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1101\/gr.258640.119","volume":"30","author":"L-X Chen","year":"2020","unstructured":"Chen, L.-X., Anantharaman, K., Shaiber, A., Eren, A. M. & Banfield, J. F. Accurate and complete genomes from metagenomes. Genome Res 30, 315\u2013333 (2020).","journal-title":"Genome Res"},{"key":"607_CR71","doi-asserted-by":"publisher","unstructured":"Borer, B. & Magn\u00fasd\u00f3ttir, S. The media composition as a crucial element in high-throughput metabolic network reconstruction. Interface Focushttps:\/\/doi.org\/10.1098\/rsfs.2022.0070 (2023).","DOI":"10.1098\/rsfs.2022.0070"},{"key":"607_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03425-1","volume":"25","author":"N De Bernardini","year":"2024","unstructured":"De Bernardini, N. et al. pan-Draft: automated reconstruction of species-representative metabolic models from multiple genomes. Genome Biol. 25, 280 (2024).","journal-title":"Genome Biol."},{"key":"607_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41596-023-00931-7","volume":"19","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Reconstruction, simulation and analysis of enzyme-constrained metabolic models using GECKO Toolbox 3.0. Nat. Protoc. 19, 629\u2013667 (2024).","journal-title":"Nat. Protoc."},{"key":"607_CR74","doi-asserted-by":"publisher","unstructured":"Liu, X. et al. Deep learning-driven automatic reconstruction of genome-scale metabolic networks. Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-2605759\/v1 (2023).","DOI":"10.21203\/rs.3.rs-2605759\/v1"},{"key":"607_CR75","doi-asserted-by":"publisher","unstructured":"Faria, J. P. et al. ModelSEED v2: High-throughput genome-scale metabolic model reconstruction with enhanced energy biosynthesis pathway prediction. https:\/\/doi.org\/10.1101\/2023.10.04.556561 (2023).","DOI":"10.1101\/2023.10.04.556561"},{"key":"607_CR76","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/bioinformatics\/btab622","volume":"37","author":"A Heinken","year":"2021","unstructured":"Heinken, A., Magn\u00fasd\u00f3ttir, S., Fleming, R. M. T. & Thiele, I. DEMETER: efficient simultaneous curation of genome-scale reconstructions guided by experimental data and refined gene annotations. Bioinformatics 37, 3974\u20133975 (2021).","journal-title":"Bioinformatics"},{"key":"607_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55041-w","volume":"9","author":"J Aminian-Dehkordi","year":"2019","unstructured":"Aminian-Dehkordi, J., Mousavi, S. M., Jafari, A., Mijakovic, I. & Marashi, S.-A. Manually curated genome-scale reconstruction of the metabolic network of Bacillus megaterium DSM319. Sci. Rep. 9, 18762 (2019).","journal-title":"Sci. Rep."},{"key":"607_CR78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nbt.1614","volume":"28","author":"JD Orth","year":"2010","unstructured":"Orth, J. D., Thiele, I. & Palsson, B. \u00d8 What is flux balance analysis?. Nat. Biotechnol. 28, 245\u2013248 (2010).","journal-title":"Nat. Biotechnol."},{"key":"607_CR79","doi-asserted-by":"publisher","first-page":"e1002363","DOI":"10.1371\/journal.pcbi.1002363","volume":"8","author":"AR Zomorrodi","year":"2012","unstructured":"Zomorrodi, A. R. & Maranas, C. D. OptCom: a multi-level optimization framework for the metabolic modeling and analysis of microbial communities. PLoS Comput Biol. 8, e1002363 (2012).","journal-title":"PLoS Comput Biol."},{"key":"607_CR80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/msystems.00606-19","volume":"5","author":"C Diener","year":"2020","unstructured":"Diener, C., Gibbons, S. M. & Resendis-Antonio, O. MICOM: Metagenome-scale modeling to infer metabolic interactions in the gut Microbiota. mSystems 5, 10\u20131128 (2020).","journal-title":"mSystems"},{"key":"607_CR81","doi-asserted-by":"publisher","first-page":"e64567","DOI":"10.1371\/journal.pone.0064567","volume":"8","author":"RA Khandelwal","year":"2013","unstructured":"Khandelwal, R. A., Olivier, B. G., R\u00f6ling, W. F. M., Teusink, B. & Bruggeman, F. J. Community flux balance analysis for microbial consortia at balanced growth. PLoS One 8, e64567 (2013).","journal-title":"PLoS One"},{"key":"607_CR82","doi-asserted-by":"publisher","first-page":"e1005539","DOI":"10.1371\/journal.pcbi.1005539","volume":"13","author":"SHJ Chan","year":"2017","unstructured":"Chan, S. H. J., Simons, M. N. & Maranas, C. D. SteadyCom: Predicting microbial abundances while ensuring community stability. PLoS Comput Biol. 13, e1005539 (2017).","journal-title":"PLoS Comput Biol."},{"key":"607_CR83","doi-asserted-by":"publisher","first-page":"e1009589","DOI":"10.1371\/journal.pcbi.1009589","volume":"17","author":"S Ravi","year":"2021","unstructured":"Ravi, S. & Gunawan, R. \u0394FBA-Predicting metabolic flux alterations using genome-scale metabolic models and differential transcriptomic data. PLoS Comput. Biol. 17, e1009589 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"607_CR84","doi-asserted-by":"publisher","first-page":"e5150","DOI":"10.1002\/pro.5150","volume":"33","author":"F Zare","year":"2024","unstructured":"Zare, F. & Fleming, R. M. T. Integration of proteomic data with genome-scale metabolic models: A methodological overview. Protein Sci. 33, e5150 (2024).","journal-title":"Protein Sci."},{"key":"607_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009337","volume":"18","author":"M Di Filippo","year":"2022","unstructured":"Di Filippo, M. et al. INTEGRATE: Model-based multi-omics data integration to characterize multi-level metabolic regulation. PLoS Comput. Biol. 18, e1009337 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"607_CR86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41540-018-0048-1","volume":"4","author":"H Cordes","year":"2018","unstructured":"Cordes, H., Thiel, C., Baier, V., Blank, L. M. & Kuepfer, L. Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbation. NPJ Syst. Biol. Appl. 4, 10 (2018).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"607_CR87","first-page":"105","volume":"6","author":"S O\u2019Hagan","year":"2015","unstructured":"O\u2019Hagan, S. & Kell, D. B. Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites. Front. Pharmacol. 6, 105 (2015).","journal-title":"Front. Pharmacol."},{"key":"607_CR88","doi-asserted-by":"publisher","first-page":"110380","DOI":"10.1016\/j.cbi.2023.110380","volume":"374","author":"E Milanetti","year":"2023","unstructured":"Milanetti, E., Miotto, M., Bo, L., Di Rienzo, L. & Ruocco, G. Investigating the competition between ACE2 natural molecular interactors and SARS-CoV-2 candidate inhibitors. Chem. Biol. Interact. 374, 110380 (2023).","journal-title":"Chem. Biol. Interact."},{"key":"607_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","volume":"117","author":"NR Latorraca","year":"2017","unstructured":"Latorraca, N. R., Venkatakrishnan, A. J. & Dror, R. O. GPCR dynamics: Structures in motion. Chem. Rev. 117, 139\u2013155 (2017).","journal-title":"Chem. Rev."},{"key":"607_CR90","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1016\/j.csbj.2023.07.022","volume":"21","author":"L Mahmoudi Azar","year":"2023","unstructured":"Mahmoudi Azar, L. et al. Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design. Comput Struct. Biotechnol. J. 21, 4096\u20134109 (2023).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"607_CR91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40203-021-00114-w","volume":"9","author":"MF Isaac-Lam","year":"2021","unstructured":"Isaac-Lam, M. F. Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. Silico Pharm. 9, 55 (2021).","journal-title":"Silico Pharm."},{"key":"607_CR92","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41422-023-00914-z","volume":"34","author":"F Li","year":"2024","unstructured":"Li, F. et al. Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2\/3. Cell Res 34, 323\u2013326 (2024).","journal-title":"Cell Res"},{"key":"607_CR93","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s12551-021-00876-9","volume":"13","author":"DP Tieleman","year":"2021","unstructured":"Tieleman, D. P. et al. Insights into lipid-protein interactions from computer simulations. Biophys. Rev. 13, 1019\u20131027 (2021).","journal-title":"Biophys. Rev."},{"key":"607_CR94","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","volume":"4","author":"SS Ghosh","year":"2020","unstructured":"Ghosh, S. S., Wang, J., Yannie, P. J. & Ghosh, S. Intestinal barrier dysfunction, LPS translocation, and disease development. J. Endocr. Soc. 4, bvz039 (2020).","journal-title":"J. Endocr. Soc."},{"key":"607_CR95","doi-asserted-by":"publisher","first-page":"e0214876","DOI":"10.1371\/journal.pone.0214876","volume":"14","author":"A Tervonen","year":"2019","unstructured":"Tervonen, A., Ihalainen, T. O., Nymark, S. & Hyttinen, J. Structural dynamics of tight junctions modulate the properties of the epithelial barrier. PLoS One 14, e0214876 (2019).","journal-title":"PLoS One"},{"key":"607_CR96","doi-asserted-by":"publisher","first-page":"e0184190","DOI":"10.1371\/journal.pone.0184190","volume":"12","author":"G Alberini","year":"2017","unstructured":"Alberini, G., Benfenati, F. & Maragliano, L. A refined model of claudin-15 tight junction paracellular architecture by molecular dynamics simulations. PLoS One 12, e0184190 (2017).","journal-title":"PLoS One"},{"key":"607_CR97","doi-asserted-by":"publisher","first-page":"e1007228","DOI":"10.1371\/journal.pcbi.1007228","volume":"15","author":"A Tafazzol","year":"2019","unstructured":"Tafazzol, A. & Duan, Y. Key residues in TLR4-MD2 tetramer formation identified by free energy simulations. PLOS Comput. Biol. 15, e1007228 (2019).","journal-title":"PLOS Comput. Biol."},{"key":"607_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260565","volume":"17","author":"X Wang","year":"2022","unstructured":"Wang, X., Chen, Y., Zhang, S. & Deng, J. N. Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8. PLoS One 17, e0260565 (2022).","journal-title":"PLoS One"},{"key":"607_CR99","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/molecules21080994","volume":"21","author":"J-M Billod","year":"2016","unstructured":"Billod, J.-M., Lacetera, A. & Guzm\u00e1n-Caldentey, J. & Mart\u00edn-Santamar\u00eda, S. Computational approaches to toll-like receptor 4 modulation. Molecules 21, 994 (2016).","journal-title":"Molecules"},{"key":"607_CR100","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.chom.2023.03.015","volume":"31","author":"RA Oliveira","year":"2023","unstructured":"Oliveira, R. A., Cabral, V., Torcato, I. & Xavier, K. B. Deciphering the quorum-sensing lexicon of the gut microbiota. Cell Host Microbe 31, 500\u2013512 (2023).","journal-title":"Cell Host Microbe"},{"key":"607_CR101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/1061186X.2020.1824235","volume":"29","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Pan, X., Wang, L. & Chen, L. Iron metabolism in biofilm and the involved iron-targeted anti-biofilm strategies. J. Drug Target 29, 249\u2013258 (2021).","journal-title":"J. Drug Target"},{"key":"607_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101695","volume":"23","author":"F Uhlig","year":"2020","unstructured":"Uhlig, F. et al. Identification of a quorum sensing-dependent communication pathway mediating bacteria-gut-brain cross talk. iScience 23, 101695 (2020).","journal-title":"iScience"},{"key":"607_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42833-4","volume":"13","author":"M Murali","year":"2023","unstructured":"Murali, M. et al. Exploration of CviR-mediated quorum sensing inhibitors from Cladosporium spp. against Chromobacterium violaceum through computational studies. Sci. Rep. 13, 15505 (2023).","journal-title":"Sci. Rep."},{"key":"607_CR104","doi-asserted-by":"publisher","first-page":"25605","DOI":"10.1021\/acsomega.0c02483","volume":"5","author":"M Venkatramanan","year":"2020","unstructured":"Venkatramanan, M. et al. Inhibition of Quorum Sensing and Biofilm Formation in by Fruit Extracts of. ACS Omega 5, 25605\u201325616 (2020).","journal-title":"ACS Omega"},{"key":"607_CR105","unstructured":"Shapiro, L. & Losick, R. Cell Biology of Bacteria: A Subject Collection from Cold Spring Harbor Perspectives in Biology. (2011)."},{"key":"607_CR106","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03187-2","volume":"12","author":"S Devi","year":"2022","unstructured":"Devi, S., Chhibber, S. & Harjai, K. Optimization of cultural conditions for enhancement of anti-quorum sensing potential in the probiotic strain GG against. 3 Biotech 12, 133 (2022).","journal-title":"3 Biotech"},{"key":"607_CR107","doi-asserted-by":"publisher","unstructured":"Abisado, R. G., Benomar, S., Klaus, J. R., Dandekar, A. A. & Chandler, J. R. Bacterial Quorum Sensing and Microbial Community Interactions. mBiohttps:\/\/doi.org\/10.1128\/mbio.02331-17 (2018).","DOI":"10.1128\/mbio.02331-17"},{"key":"607_CR108","doi-asserted-by":"crossref","unstructured":"Kalia, V. C. Biotechnological Applications of Quorum Sensing Inhibitors. (Springer, 2018).","DOI":"10.1007\/978-981-10-9026-4"},{"key":"607_CR109","doi-asserted-by":"publisher","first-page":"31385","DOI":"10.1039\/D0RA03167D","volume":"10","author":"DPP Shanmugarajan","year":"2020","unstructured":"Shanmugarajan, D. P. P., Kumar, B. R. P. & Suresh, B. Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: Computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets. RSC Adv. 10, 31385\u201331399 (2020).","journal-title":"RSC Adv."},{"key":"607_CR110","doi-asserted-by":"publisher","first-page":"34033","DOI":"10.1039\/D0RA06424F","volume":"10","author":"MA Mansour","year":"2020","unstructured":"Mansour, M. A., AboulMagd, A. M. & Abdel-Rahman, H. M. Quinazoline-Schiff base conjugates: study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins. RSC Adv. 10, 34033\u201334045 (2020).","journal-title":"RSC Adv."},{"key":"607_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42015-2","volume":"13","author":"A Da","year":"2023","unstructured":"Da, A., Wu-Lu, M., Dragelj, J., Mroginski, M. A. & Ebrahimi, K. H. Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cells. Sci. Rep. 13, 16387 (2023).","journal-title":"Sci. Rep."},{"key":"607_CR112","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"607_CR113","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","volume":"52","author":"OO Onabajo","year":"2020","unstructured":"Onabajo, O. O. et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat. Genet. 52, 1283\u20131293 (2020).","journal-title":"Nat. Genet."},{"key":"607_CR114","doi-asserted-by":"publisher","first-page":"e2100425118","DOI":"10.1073\/pnas.2100425118","volume":"118","author":"AR Mehdipour","year":"2021","unstructured":"Mehdipour, A. R. & Hummer, G. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc. Natl. Acad. Sci. USA 118, e2100425118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"607_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12780-8","volume":"10","author":"M Menon","year":"2019","unstructured":"Menon, M. et al. Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration. Nat. Commun. 10, 4902 (2019).","journal-title":"Nat. Commun."},{"key":"607_CR116","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41594-022-00910-8","volume":"30","author":"DF Burke","year":"2023","unstructured":"Burke, D. F. et al. Towards a structurally resolved human protein interaction network. Nat. Struct. Mol. Biol. 30, 216\u2013225 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"607_CR117","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"607_CR118","doi-asserted-by":"publisher","unstructured":"Drake, Z. C., Seffernick, J. T. & Lindert, S. Protein complex prediction using Rosetta, AlphaFold, and mass spectrometry covalent labeling. bioRxivhttps:\/\/doi.org\/10.1101\/2022.04.30.490108 (2022).","DOI":"10.1101\/2022.04.30.490108"},{"key":"607_CR119","doi-asserted-by":"publisher","first-page":"28046","DOI":"10.1073\/pnas.2016093117","volume":"117","author":"A Glasgow","year":"2020","unstructured":"Glasgow, A. et al. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proc. Natl. Acad. Sci. USA 117, 28046\u201328055 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"607_CR120","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/acsptsci.2c00180","volume":"6","author":"F Renzi","year":"2023","unstructured":"Renzi, F. et al. Engineering an ACE2-derived fragment as a decoy for novel SARS-CoV-2 virus. ACS Pharmacol. Transl. Sci. 6, 857\u2013867 (2023).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"607_CR121","doi-asserted-by":"publisher","first-page":"RP94029","DOI":"10.7554\/eLife.94029.3","volume":"13","author":"A Harmalkar","year":"2025","unstructured":"Harmalkar, A., Lyskov, S. & Gray, J. J. Reliable protein-protein docking with AlphaFold, Rosetta, and replica exchange. Elife 13, RP94029 (2025).","journal-title":"Elife"},{"key":"607_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/TIM.2022.3171613","volume":"71","author":"MS Kamal","year":"2022","unstructured":"Kamal, M. S., Dey, N., Chowdhury, L., Hasan, S. I. & Santosh, K. C. Explainable AI for glaucoma prediction analysis to understand risk factors in treatment planning. IEEE Trans. Instrum. Meas. 71, 1\u20139 (2022).","journal-title":"IEEE Trans. Instrum. Meas."},{"key":"607_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1348974","volume":"15","author":"P Novielli","year":"2024","unstructured":"Novielli, P. et al. Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification. Front Microbiol 15, 1348974 (2024).","journal-title":"Front Microbiol"},{"key":"607_CR124","doi-asserted-by":"publisher","first-page":"e0004923","DOI":"10.1128\/spectrum.00049-23","volume":"11","author":"K Serebrinsky-Duek","year":"2023","unstructured":"Serebrinsky-Duek, K., Barra, M., Danino, T. & Garrido, D. Engineered bacteria for short-chain-fatty-acid-repressed expression of biotherapeutic molecules. Microbiol Spectr. 11, e0004923 (2023).","journal-title":"Microbiol Spectr."},{"key":"607_CR125","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","volume":"20","author":"A Cubillos-Ruiz","year":"2021","unstructured":"Cubillos-Ruiz, A. et al. Engineering living therapeutics with synthetic biology. Nat. Rev. Drug Discov. 20, 941\u2013960 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"607_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18614-2","volume":"11","author":"BB Hsu","year":"2020","unstructured":"Hsu, B. B. et al. In situ reprogramming of gut bacteria by oral delivery. Nat. Commun. 11, 5030 (2020).","journal-title":"Nat. Commun."},{"key":"607_CR127","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","volume":"14","author":"A Verma","year":"2019","unstructured":"Verma, A. et al. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol. Ther. Methods Clin. Dev. 14, 161\u2013170 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"607_CR128","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"607_CR129","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi, M. et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res 126, 1456\u20131474 (2020).","journal-title":"Circ. Res"},{"key":"607_CR130","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.4014\/jmb.2407.07004","volume":"34","author":"TH Kim","year":"2024","unstructured":"Kim, T. H., Cho, B. K. & Lee, D.-H. Synthetic biology-driven microbial therapeutics for disease treatment. J. Microbiol. Biotechnol. 34, 1947\u20131958 (2024).","journal-title":"J. Microbiol. Biotechnol."},{"key":"607_CR131","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1002\/bit.28770","volume":"121","author":"S Galvan","year":"2024","unstructured":"Galvan, S., Teixeira, A. P. & Fussenegger, M. Enhancing cell-based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnol. Bioeng. 121, 2987\u20133000 (2024).","journal-title":"Biotechnol. Bioeng."},{"key":"607_CR132","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.aau7187","volume":"368","author":"K Krawczyk","year":"2020","unstructured":"Krawczyk, K. et al. Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science 368, 993\u20131001 (2020).","journal-title":"Science"},{"key":"607_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-016-0005","volume":"1","author":"H Ye","year":"2017","unstructured":"Ye, H. et al. Self-adjusting synthetic gene circuit for correcting insulin resistance. Nat. Biomed. Eng. 1, 0005 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"607_CR134","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2337\/db22-0860","volume":"72","author":"L Xie","year":"2023","unstructured":"Xie, L. et al. Glucose-activated switch regulating insulin analog secretion enables long-term precise glucose control in mice with type 1 diabetes. Diabetes 72, 703\u2013714 (2023).","journal-title":"Diabetes"},{"key":"607_CR135","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fbioe.2020.00265","volume":"8","author":"M Barra","year":"2020","unstructured":"Barra, M., Danino, T. & Garrido, D. Engineered probiotics for detection and treatment of inflammatory intestinal diseases. Front. Bioeng. Biotechnol. 8, 265 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"607_CR136","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos, A., Z\u00fa\u00f1iga-Miranda, J., Carrera-Pacheco, S. E., Barba-Ostria, C. & Guam\u00e1n, L. P. CRISPR-Cas-based antimicrobials: Design, challenges, and bacterial mechanisms of resistance. ACS Infect. Dis. 9, 1283\u20131302 (2023).","journal-title":"ACS Infect. Dis."},{"key":"607_CR137","doi-asserted-by":"publisher","first-page":"123029","DOI":"10.1016\/j.biomaterials.2024.123029","volume":"317","author":"J-N Jiang","year":"2025","unstructured":"Jiang, J.-N., Kong, F.-H., Lei, Q. & Zhang, X.-Z. Surface-functionalized bacteria: Frontier explorations in next-generation live biotherapeutics. Biomaterials 317, 123029 (2025).","journal-title":"Biomaterials"},{"key":"607_CR138","doi-asserted-by":"publisher","unstructured":"Ates, A., Tastan, C. & Ermertcan, S. Precision genome editing unveils a breakthrough in reversing antibiotic resistance: CRISPR\/Cas9 targeting of multi-drug resistance genes in methicillin-resistantStaphylococcus aureus. bioRxiv https:\/\/doi.org\/10.1101\/2023.12.31.573511 (2024).","DOI":"10.1101\/2023.12.31.573511"},{"key":"607_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05834-z","volume":"22","author":"Q Yi","year":"2024","unstructured":"Yi, Q., Ouyang, X., Zhu, G. & Zhong, J. Letter: The risk-benefit balance of CRISPR-Cas screening systems in gene editing and targeted cancer therapy. J. Transl. Med. 22, 1005 (2024).","journal-title":"J. Transl. Med"},{"key":"607_CR140","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fimmu.2019.01486","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas, D. et al. Corrigendum: Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 10, 1486 (2019).","journal-title":"Front Immunol."},{"key":"607_CR141","doi-asserted-by":"publisher","first-page":"19376","DOI":"10.1073\/pnas.2000047117","volume":"117","author":"SA Scott","year":"2020","unstructured":"Scott, S. A., Fu, J. & Chang, P. V. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 117, 19376\u201319387 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"607_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat. Commun. 13, 3432 (2022).","journal-title":"Nat. Commun."},{"key":"607_CR143","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ph15050644","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang, X. Microencapsulating alginate-based polymers for probiotics delivery systems and their application. Pharmaceuticals (Basel) 15, 644 (2022).","journal-title":"Pharmaceuticals (Basel)"},{"key":"607_CR144","doi-asserted-by":"publisher","unstructured":"Oh, J.-H. et al. Secretion of recombinant interleukin-22 by engineered lactobacillus reuteri reduces fatty liver disease in a mouse model of diet-induced obesity. mSphere https:\/\/doi.org\/10.1128\/msphere.00183-20 (2020).","DOI":"10.1128\/msphere.00183-20"},{"key":"607_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19455-3","volume":"12","author":"EB Nogu\u00e8s","year":"2022","unstructured":"Nogu\u00e8s, E. B. et al. Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL\/6 mice by promoting IL17A and IL10 cytokine expression. Sci. Rep. 12, 15641 (2022).","journal-title":"Sci. Rep."},{"key":"607_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-021-01718-9","volume":"21","author":"J Ma","year":"2022","unstructured":"Ma, J. et al. Correction to: Engineered probiotics. Microb. Cell Fact. 21, 1\u20131 (2022).","journal-title":"Microb. Cell Fact."},{"key":"607_CR147","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1021\/acssynbio.4c00036","volume":"13","author":"N Weibel","year":"2024","unstructured":"Weibel, N. et al. Engineering a novel probiotic toolkit in for sensing and mitigating gut inflammatory diseases. ACS Synth. Biol. 13, 2376\u20132390 (2024).","journal-title":"ACS Synth. Biol."},{"key":"607_CR148","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.122.322003","volume":"132","author":"R Prasad","year":"2023","unstructured":"Prasad, R. et al. Maintenance of enteral ACE2 prevents diabetic retinopathy in type 1 diabetes. Circ. Res. 132, e1\u2013e21 (2023).","journal-title":"Circ. Res."},{"key":"607_CR149","first-page":"323","volume":"65","author":"S Paul","year":"2024","unstructured":"Paul, S. et al. An engineered probiotic expressing Ang1-7 minimizes the risk of developing diabetic retinopathy in db\/db mice. Invest. Ophthalmol. Vis. Sci. 65, 323\u2013323 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"607_CR150","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1002\/mef2.28","volume":"1","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Dysbiosis of gut microbiome contributes to glaucoma pathogenesis. MedComm - Fut. Med. 1, e28 (2022).","journal-title":"MedComm - Fut. Med."},{"key":"607_CR151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s10020-020-00234-7","volume":"26","author":"M Li","year":"2020","unstructured":"Li, M., Chen, W.-D. & Wang, Y.-D. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol. Med. 26, 101 (2020).","journal-title":"Mol. Med."},{"key":"607_CR152","doi-asserted-by":"publisher","first-page":"110739","DOI":"10.1016\/j.diabres.2023.110739","volume":"201","author":"F Fardi","year":"2023","unstructured":"Fardi, F. et al. An interplay between non-coding RNAs and gut microbiota in human health. Diab. Res. Clin. Pract. 201, 110739 (2023).","journal-title":"Diab. Res. Clin. Pract."},{"key":"607_CR153","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/msb.2009.57","volume":"5","author":"DS Lun","year":"2009","unstructured":"Lun, D. S. et al. Large-scale identification of genetic design strategies using local search. Mol. Syst. Biol. 5, 296 (2009).","journal-title":"Mol. Syst. Biol."},{"key":"607_CR154","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.compbiolchem.2016.02.014","volume":"61","author":"D Gu","year":"2016","unstructured":"Gu, D., Zhang, C., Zhou, S., Wei, L. & Hua, Q. IdealKnock: A framework for efficiently identifying knockout strategies leading to targeted overproduction. Comput Biol. Chem. 61, 229\u2013237 (2016).","journal-title":"Comput Biol. Chem."},{"key":"607_CR155","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.synbio.2023.09.002","volume":"8","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Improving pathway prediction accuracy of constraints-based metabolic network models by treating enzymes as microcompartments. Synth. Syst. Biotechnol. 8, 597\u2013605 (2023).","journal-title":"Synth. Syst. Biotechnol."},{"key":"607_CR156","doi-asserted-by":"publisher","first-page":"E6457","DOI":"10.1073\/pnas.1617508114","volume":"114","author":"A-M Reimers","year":"2017","unstructured":"Reimers, A.-M., Knoop, H., Bockmayr, A. & Steuer, R. Cellular trade-offs and optimal resource allocation during cyanobacterial diurnal growth. Proc. Natl. Acad. Sci. Usa. 114, E6457\u2013E6465 (2017).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"607_CR157","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/metabo7030047","volume":"7","author":"A-M Reimers","year":"2017","unstructured":"Reimers, A.-M., Lindhorst, H. & Waldherr, S. A Protocol for Generating and Exchanging (Genome-Scale) Metabolic Resource Allocation Models. Metabolites 7, 47 (2017).","journal-title":"Metabolites"},{"key":"607_CR158","doi-asserted-by":"publisher","first-page":"20120671","DOI":"10.1098\/rsif.2012.0671","volume":"10","author":"DA Oyarz\u00fan","year":"2013","unstructured":"Oyarz\u00fan, D. A. & Stan, G.-B. V. Synthetic gene circuits for metabolic control: design trade-offs and constraints. J. R. Soc. Interface 10, 20120671 (2013).","journal-title":"J. R. Soc. Interface"},{"key":"607_CR159","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/acssynbio.8b00078","volume":"8","author":"L Watanabe","year":"2019","unstructured":"Watanabe, L. et al. iBioSim 3: A tool for model-based genetic circuit design. ACS Synth. Biol. 8, 1560\u20131563 (2019).","journal-title":"ACS Synth. Biol."},{"key":"607_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05599-0","volume":"24","author":"T Paklao","year":"2023","unstructured":"Paklao, T., Suratanee, A. & Plaimas, K. ICON-GEMs: Integration of co-expression network in genome-scale metabolic models, shedding light through systems biology. BMC Bioinforma. 24, 492 (2023).","journal-title":"BMC Bioinforma."},{"key":"607_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-5-147","volume":"5","author":"PA Jensen","year":"2011","unstructured":"Jensen, P. A., Lutz, K. A. & Papin, J. A. TIGER: Toolbox for integrating genome-scale metabolic models, expression data, and transcriptional regulatory networks. BMC Syst. Biol. 5, 147 (2011).","journal-title":"BMC Syst. Biol."},{"key":"607_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-022-00499-9","volume":"14","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease. Gut Pathog. 14, 26 (2022).","journal-title":"Gut Pathog."},{"key":"607_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-021-00178-6","volume":"7","author":"A Heinken","year":"2021","unstructured":"Heinken, A., Hertel, J. & Thiele, I. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis. NPJ Syst. Biol. Appl. 7, 19 (2021).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"607_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008487","volume":"17","author":"P Patumcharoenpol","year":"2021","unstructured":"Patumcharoenpol, P. et al. MetGEMs Toolbox: Metagenome-scale models as integrative toolbox for uncovering metabolic functions and routes of human gut microbiome. PLoS Comput. Biol. 17, e1008487 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"607_CR165","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/metabo14030132","volume":"14","author":"G Bidkhori","year":"2024","unstructured":"Bidkhori, G. & Shoaie, S. MIGRENE: The toolbox for microbial and individualized GEMs, reactobiome and community network modelling. Metabolites 14, 132 (2024).","journal-title":"Metabolites"},{"key":"607_CR166","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/cea.13746","volume":"50","author":"Y Yao","year":"2020","unstructured":"Yao, Y., Wang, H. & Liu, Z. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin. Exp. Allergy 50, 1313\u20131324 (2020).","journal-title":"Clin. Exp. Allergy"},{"key":"607_CR167","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.03185-20","volume":"11","author":"J Nascimento Conde","year":"2020","unstructured":"Nascimento Conde, J., Schutt, W. R., Gorbunova, E. E. & Mackow, E. R. Recombinant ACE2 expression is required for SARS-CoV-2 to infect primary human endothelial cells and induce inflammatory and procoagulative responses. MBio 11, 10\u20131128 (2020).","journal-title":"MBio"},{"key":"607_CR168","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-020-00307-w","volume":"6","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs. Cell Death Discov. 6, 76 (2020).","journal-title":"Cell Death Discov."},{"key":"607_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92979-2","volume":"11","author":"T Toyonaga","year":"2021","unstructured":"Toyonaga, T. et al. Increased colonic expression of ACE2 associates with poor prognosis in Crohn\u2019s disease. Sci. Rep. 11, 13533 (2021).","journal-title":"Sci. Rep."},{"key":"607_CR170","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s42255-021-00430-7","volume":"3","author":"MK Puurunen","year":"2021","unstructured":"Puurunen, M. K. et al. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: A first-in-human phase 1\/2a study. Nat. Metab. 3, 1125\u20131132 (2021).","journal-title":"Nat. Metab."},{"key":"607_CR171","doi-asserted-by":"crossref","unstructured":"Microbiome Therapeutics Innovation Group & Barberio, D. Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing. Front. Microbiomes 3, 1441290 (2024).","DOI":"10.3389\/frmbi.2024.1441290"},{"key":"607_CR172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.BAD-0017-2017","volume":"5","author":"SM Dreher-Lesnick","year":"2017","unstructured":"Dreher-Lesnick, S. M., Stibitz, S. & Carlson, P. E. U.S. regulatory considerations for development of live biotherapeutic products as drugs. Microbiol Spectr 5, 10\u20131128 (2017).","journal-title":"Microbiol Spectr"},{"key":"607_CR173","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","volume":"52","author":"M Cordaillat-Simmons","year":"2020","unstructured":"Cordaillat-Simmons, M., Rouanet, A. & Pot, B. Live biotherapeutic products: The importance of a defined regulatory framework. Exp. Mol. Med. 52, 1397\u20131406 (2020).","journal-title":"Exp. Mol. Med."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00607-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:04:29Z","timestamp":1763733869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00607-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":173,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00607-w","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}